The Impracticality of Relying on Compulsory Licenses to Expand Production Capacity for COVID-19 Vaccines

“The EU and other waiver-blocking countries must face the facts that IP barriers must be removed if we are to survive this viral plague,” writes Professor Brook Baker ‘76, senior policy analyst for Health GAP (Global Access Project), in his latest post for Infojustice.